Charles Schwab’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Sell |
89,705
-35,909
| -29% | -$40.2K | ﹤0.01% | 3416 |
|
|
2025
Q1 | $144K | Sell |
125,614
-32,229
| -20% | -$37.1K | ﹤0.01% | 3296 |
|
|
2024
Q4 | $964K | Buy |
157,843
+9,441
| +6% | +$57.7K | ﹤0.01% | 2925 |
|
|
2024
Q3 | $2.45M | Buy |
148,402
+16,072
| +12% | +$266K | ﹤0.01% | 2647 |
|
|
2024
Q2 | $909K | Buy |
132,330
+11,212
| +9% | +$77K | ﹤0.01% | 2974 |
|
|
2024
Q1 | $1.17M | Buy |
121,118
+301
| +0.2% | +$2.91K | ﹤0.01% | 2741 |
|
|
2023
Q4 | $1M | Buy |
120,817
+21,052
| +21% | +$175K | ﹤0.01% | 2829 |
|
|
2023
Q3 | $833K | Buy |
99,765
+2,472
| +3% | +$20.6K | ﹤0.01% | 2862 |
|
|
2023
Q2 | $898K | Buy |
97,293
+3,477
| +4% | +$32.1K | ﹤0.01% | 2809 |
|
|
2023
Q1 | $1.29M | Buy |
93,816
+22,470
| +31% | +$309K | ﹤0.01% | 2654 |
|
|
2022
Q4 | $1.21M | Buy |
71,346
+1,250
| +2% | +$21.3K | ﹤0.01% | 2717 |
|
|
2022
Q3 | $1.59M | Buy |
70,096
+4,811
| +7% | +$109K | ﹤0.01% | 2643 |
|
|
2022
Q2 | $1.18M | Sell |
65,285
-37,338
| -36% | -$674K | ﹤0.01% | 2735 |
|
|
2022
Q1 | $2.74M | Buy |
102,623
+45,502
| +80% | +$1.22M | ﹤0.01% | 2542 |
|
|
2021
Q4 | $1.68M | Buy |
57,121
+1,254
| +2% | +$36.8K | ﹤0.01% | 2753 |
|
|
2021
Q3 | $3.67M | Buy |
55,867
+4,986
| +10% | +$328K | ﹤0.01% | 2517 |
|
|
2021
Q2 | $4.23M | Buy |
50,881
+1,848
| +4% | +$154K | ﹤0.01% | 2427 |
|
|
2021
Q1 | $3.76M | Buy |
49,033
+3,654
| +8% | +$280K | ﹤0.01% | 2430 |
|
|
2020
Q4 | $4.01M | Sell |
45,379
-538
| -1% | -$47.5K | ﹤0.01% | 2329 |
|
|
2020
Q3 | $3.39M | Sell |
45,917
-22,571
| -33% | -$1.67M | ﹤0.01% | 2262 |
|
|
2020
Q2 | $5M | Buy |
68,488
+8,998
| +15% | +$657K | ﹤0.01% | 2028 |
|
|
2020
Q1 | $3.34M | Buy |
59,490
+1,050
| +2% | +$59K | ﹤0.01% | 2038 |
|
|
2019
Q4 | $2.23M | Buy |
+58,440
| New | +$2.23M | ﹤0.01% | 2379 |
|